Catalog excerpts
The first transcatheter device designed to deliver The Right Solution for the Right Side Edwards Cardioband Tricuspid Valve Reconstruction System
Open the catalog to page 1Tricuspid regurgitation is largely undertreated. Patient mortality is significant. one-year mortality rate for patients with severe tricuspid regurgitation2 • any patients diagnosed with tricuspid regurgitation are M medically managed • atients may experience debilitating symptoms, with few P treatment options
Open the catalog to page 2The first-ever, CE Marked transcatheter tricuspid annular reduction system Cardioband Tricuspid Valve Reconstruction System. Designed to safely and effectively reduce tricuspid regurgitation through annular reduction.3 Restores valve to a more functional state, facilitating leaflet coaptation nables annular reduction based on each patient’s anatomy E Supports real-time adjustment and confirmation of procedural results
Open the catalog to page 3Edwards Cardioband Tricuspid Valve Reconstruction System Facilitates leaflet coaptation. Preserves native anatomy. Cardioband Tricuspid System addresses the main physiological cause of tricuspid regurgitation: annular dilatation. •S upra-annular fixation preserves native anatomy— keeping future treatment options open Real-time intraprocedural adjustment and confirmation of results ECHO AT BASELINE Transesophageal echocardiogram (TEE) shows tricuspid regurgitation at baseline Images courtesy of Bonn University Hospital ECHO POST-PROCEDURE Real-time, intra-procedural confirmation of reduction...
Open the catalog to page 4A reproducible and standardised procedure. Precise positioning in patient anatomy 1. Access Insert Cardioband delivery system into the right atrium using a transfemoral approach. 2. Deploy Deploy implant via a steerable catheter to navigate around the tricuspid annulus, securing the implant with stainless steel anchors. 3. Adjust and Reduce TR Introduce the size adjustment tool over a wire and rotate the adjustment knob clockwise for implant contraction.
Open the catalog to page 5Clinical results show the Cardioband Tricuspid System safely and effectively reduces tricuspid regurgitation and improves quality of life.3
Open the catalog to page 6Edwards Cardioband Tricuspid Valve Reconstruction System the annulus based on each patient’s anatomy with real-time confirmation of results the valve to a more functional state Driven by a passion to help patients. With the first-ever introduction of an advanced, CE Marked transcatheter solution for the treatment of tricuspid regurgitation, Edwards Lifesciences continues to innovate in meaningful and lasting ways for both physicians and patients. For more information, please visit www.edwards.com/CardiobandTR References 1. Fender EA, Zack CJ, Nishimura RA. Isolated tricuspid regurgitation:...
Open the catalog to page 8All Edwards Lifesciences catalogs and technical brochures
-
EVOQUE
7 Pages
-
PASCAL
4 Pages
-
VAMP adult system
5 Pages
-
PediaSat Oximetry Catheter
5 Pages
-
OptiSite
2 Pages
-
Edwards Fogarty® Catheters.
3 Pages
-
Vascular Therapies
28 Pages
-
ev 1000 brochure
5 Pages
-
ED MagnaEase Bro
3 Pages
-
MagNa PerForMaNce MiTraleaSe
4 Pages
-
VAMP Adult Brochure
4 Pages
-
Swan-Ganz Brochure
6 Pages
-
ccNexfin System
3 Pages
-
PediaSat
4 Pages
-
Sepsis_management
4 Pages
-
Global Myocardial Protection
4 Pages
-
Edwards Protection Cannulae
119 Pages
-
Fluid Optimization
3 Pages
-
Flo Trac
4 Pages
-
Retrogradebrochure
4 Pages
-
Venous Cannulae
4 Pages
-
Arterial Cannulae
4 Pages
-
EV1000 Clinical Platform
5 Pages
-
PediaSat Catheter
4 Pages
-
PreSep Catheter
6 Pages
-
VolumeView Set
4 Pages
-
FloTrac Sensor
4 Pages
-
Product catalog
28 Pages